7Baggers

Integra LifeSciences Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Cash and Cash Eq  
 Deferred Revenue  
 Inventory  
20180331 20180630 20180930 20181231 20190331 20190630 20190930 20191231 20200331 20201231 20211231 20221231 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 00.160.320.480.640.80.961.12Billion

Integra LifeSciences Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2022-12-31 2021-12-31 2020-12-31 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-06-22 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2001-03-31 
                                                                    
  assets                                                                  
  current assets:                                                                  
  cash and cash equivalents217,914,000 239,104,000 246,375,000 215,157,000 215,236,000 591,906,000 276,402,000 273,732,000 456,661,000 513,448,000 470,166,000 357,712,000 198,911,000 207,981,000 176,084,000 157,025,000 138,838,000 205,991,000 183,771,000 189,396,000 481,943,000 154,600,000 124,113,000 102,055,000 107,598,000 86,803,000  77,086,000 48,132,000 79,311,000 131,296,000 79,871,000 71,994,000 140,231,000 137,160,000 129,038,000 120,614,000 118,868,000 98,636,000 89,691,000 96,938,000 125,718,000 75,470,000 58,642,000 100,808,000 110,991,000 137,279,000 104,354,000 128,763,000 82,832,000 93,618,000 81,674,000 71,891,000 106,747,000 138,717,000 185,630,000 183,546,000 109,339,000 77,338,000 199,013,000 57,339,000 129,498,000 120,838,000 29,329,000 22,697,000 15,392,000 
  short-term investments35,694,000 34,191,000 27,192,000 62,441,000 81,691,000 71,194,000 32,694,000                11,286,000                    39,315,000 53,780,000                      3,982,000 
  trade accounts receivable, net of allowances of 6,852 and 6,917284,507,000                                                                  
  inventories465,127,000 445,418,000 429,090,000 436,930,000 421,775,000 403,422,000 389,608,000 366,251,000 324,583,000 317,386,000 310,117,000 338,082,000 316,054,000 302,622,000 296,505,000 286,962,000 280,347,000 290,846,000 290,517,000 290,474,000 232,340,000 234,680,000 239,809,000 217,263,000 219,671,000 220,442,000  221,978,000 211,429,000 213,878,000 241,835,000 233,043,000 237,114,000 230,455,000 223,632,000 215,232,000 213,431,000 207,389,000 195,457,000 179,558,000 171,806,000 169,376,000 172,541,000 172,469,000 171,261,000 181,430,000 174,460,000 154,601,000 146,928,000 147,973,000 143,253,000 142,113,000 140,240,000 140,541,000 139,319,000 141,582,000 146,103,000 155,615,000 149,345,000 144,037,000 144,535,000 126,371,000 114,089,000 95,591,000 94,387,000 18,509,000 
  prepaid expenses103,465,000 103,874,000 77,001,000 86,326,000 93,639,000 72,667,000 67,362,000                                                            
  other current assets36,121,000 32,214,000 29,653,000 50,370,000 28,790,000 35,369,000 32,643,000                                                            
  total current assets1,142,828,000 1,107,247,000 1,081,681,000 1,099,522,000 1,112,286,000 1,415,650,000 1,058,036,000 1,027,229,000 1,161,498,000 1,153,716,000 1,237,202,000 1,008,672,000 858,168,000 883,813,000 868,672,000 822,686,000 775,082,000 827,983,000 821,322,000 848,650,000 944,943,000 616,166,000 568,919,000 495,170,000 511,877,000 493,986,000  494,565,000 438,495,000 504,912,000 608,247,000 521,950,000 529,321,000 562,589,000 564,161,000 539,746,000 525,242,000 510,583,000 477,736,000 447,059,000 453,051,000 493,562,000 477,323,000 459,743,000 452,257,000 476,328,000 495,784,000 425,185,000 444,849,000 386,295,000 387,631,000 372,844,000 365,363,000 395,795,000 423,249,000 477,567,000 497,392,000 436,282,000 379,561,000 489,323,000 339,931,000 380,359,000 352,983,000 229,800,000 221,761,000 52,467,000 
  property, plant and equipment434,816,000 422,913,000 405,723,000 390,906,000 373,570,000 345,356,000 340,199,000 318,718,000 311,302,000 311,703,000 287,529,000 335,903,000 337,404,000 319,384,000 316,445,000 306,350,000 300,112,000 287,000,000 277,025,000 274,029,000 232,241,000 232,074,000 229,110,000 222,369,000 212,195,000 208,648,000  210,330,000 205,181,000 197,200,000 215,460,000 210,111,000 209,986,000 203,882,000 206,668,000 205,667,000 200,310,000 192,724,000 184,537,000 179,352,000 177,898,000 161,189,000 146,928,000   122,435,000 115,667,000   87,293,000 84,644,000   70,834,000 70,777,000 69,783,000  69,999,000 63,437,000     43,702,000   
  right of use asset - operating leases136,572,000 138,463,000 144,042,000 146,342,000 147,472,000 151,834,000 156,184,000 156,760,000 148,284,000 84,543,000 83,635,000 95,890,000 94,530,000 97,738,000 97,783,000                                                    
  intangible assets1,188,080,000 1,187,535,000 1,207,588,000 1,209,548,000 1,219,942,000 1,022,609,000 1,067,833,000 1,067,023,000 1,126,609,000 1,145,573,000 989,436,000 1,014,227,000 1,031,591,000 1,040,350,000 1,041,620,000 1,058,630,000 1,079,496,000 1,097,259,000 1,121,845,000 1,147,954,000 634,052,000 648,744,000 654,408,000 561,175,000 573,687,000 583,569,000  594,856,000 603,740,000 606,420,000 440,583,000 447,424,000 459,459,000 413,906,000 422,009,000 429,446,000 197,163,000 202,410,000 206,884,000 212,274,000 212,267,000 218,345,000 224,308,000 230,920,000 237,122,000 243,934,000 230,935,000 191,210,000 194,904,000 198,711,000 201,174,000 206,344,000 211,117,000 214,432,000 217,447,000 220,225,000 225,998,000 209,337,000 188,130,000 192,086,000 195,766,000   177,467,000 179,716,000  
  goodwill616,427,000 1,105,386,000 1,096,952,000 1,116,535,000 1,104,640,000 1,040,235,000 1,055,462,000 1,036,146,000 1,038,881,000 1,013,458,000 932,367,000 951,554,000 954,280,000 945,282,000 926,732,000 922,508,000 926,475,000 926,369,000 927,148,000 944,495,000 587,943,000 585,410,000 578,229,000 510,571,000 515,636,000 514,023,000  516,103,000 512,389,000 505,727,000 357,022,000 354,202,000 363,888,000 349,574,000 354,977,000 367,649,000 249,764,000 248,824,000 292,881,000 292,278,000 294,067,000 292,426,000 292,085,000 295,232,000 292,980,000 294,529,000 285,376,000 267,426,000 261,928,000 262,433,000 252,143,000 257,789,000 261,941,000 264,605,000 211,767,000 207,705,000 212,094,000 210,503,000 214,478,000 214,423,000 207,438,000 179,260,000 174,507,000 163,719,000 162,414,000  
  deferred tax assets102,943,000 38,008,000 34,923,000 48,936,000 45,763,000 34,175,000 46,080,000 55,587,000 45,994,000 56,950,000 73,690,000 2,330,000 12,623,000 27,005,000 22,438,000 16,404,000 6,805,000 7,234,000 7,677,000 6,464,000 6,351,000 6,214,000 4,757,000 6,935,000 7,376,000 7,062,000  7,128,000  46,897,000 58,173,000 58,293,000 58,663,000 44,276,000 48,349,000 48,459,000 46,300,000 40,049,000 38,120,000 38,470,000 39,100,000 64,575,000 62,264,000 36,285,000 36,155,000 37,800,000 35,072,000 35,306,000 35,284,000 29,839,000 29,526,000 29,444,000 29,972,000 20,939,000 21,115,000 21,325,000 24,135,000 21,234,000 21,214,000 25,075,000 22,254,000 13,562,000 13,011,000 9,555,000 10,010,000  
  other assets46,239,000 53,199,000 66,515,000 54,014,000 70,822,000 68,365,000 58,194,000 77,908,000 57,190,000 16,440,000 11,277,000 38,989,000 14,644,000 33,008,000 16,720,000 79,133,000 19,917,000 32,797,000 30,756,000 26,101,000 12,657,000 12,523,000 13,592,000 11,734,000 6,653,000 6,874,000  7,280,000 7,967,000 8,406,000 10,893,000 11,436,000 10,368,000 9,524,000 8,786,000 7,770,000 8,338,000 9,986,000 10,475,000 9,785,000 10,359,000 11,956,000 12,516,000 12,580,000 13,128,000 12,674,000 13,630,000 10,302,000 8,277,000 8,826,000 1,975,000 2,086,000 2,314,000 27,570,000 23,132,000 20,137,000 28,565,000 34,624,000 16,848,000 13,480,000 13,147,000 14,002,000 14,593,000 8,386,000 7,168,000 3,061,000 
  total assets3,667,905,000 4,052,751,000 4,037,424,000 4,065,803,000 4,074,495,000 4,078,224,000 3,781,988,000 3,739,371,000 3,889,758,000 3,782,383,000 3,615,136,000 3,447,565,000 3,303,240,000 3,346,580,000 3,290,410,000 3,205,711,000 3,107,887,000 3,178,642,000 3,185,773,000 3,247,693,000 2,418,187,000 2,101,131,000 2,049,015,000 1,807,954,000 1,827,424,000 1,814,162,000  1,830,262,000 1,774,704,000 1,827,620,000 1,637,894,000 1,550,807,000 1,578,625,000 1,545,734,000 1,563,023,000 1,555,923,000 1,196,229,000 1,184,072,000 1,187,501,000 1,156,491,000 1,163,599,000 1,185,506,000 1,161,817,000 1,158,370,000 1,144,109,000 1,174,666,000 1,153,856,000 1,007,028,000 1,017,308,000 959,276,000 941,795,000 937,997,000 940,102,000 973,236,000 946,372,000 995,417,000 1,034,431,000 960,745,000 862,454,000 972,656,000 818,012,000 810,077,000 776,490,000 623,074,000 613,618,000 91,079,000 
  liabilities and stockholders’ equity                                                                  
  current liabilities:                                                                  
  current portion of borrowings under senior credit facility38,750,000 38,750,000 33,906,000 29,063,000 24,219,000 19,375,000 14,531,000 9,687,000 38,125,000 45,000,000 33,750,000  45,000,000 45,000,000 45,000,000                                                    
  current portion of lease liability - operating leases14,176,000 14,171,000 14,540,000 15,039,000 14,613,000 16,303,000 15,284,000 14,461,000 14,624,000 14,775,000 12,818,000 12,964,000 12,253,000 11,835,000 13,448,000                                                    
  convertible securities574,628,000 573,899,000 573,170,000 572,442,000                           2,903,000                     77,470,000 76,760,000 94,233,000 110,443,000     119,380,000 119,962,000 119,962,000 119,964,000 120,000,000 119,542,000  
  accounts payable, trade92,835,000 91,296,000 82,502,000 77,666,000 107,492,000 94,397,000 92,326,000 93,550,000 102,100,000 61,837,000 54,608,000 97,061,000 113,090,000 94,158,000 107,191,000 100,553,000 76,050,000 86,380,000 84,037,000 86,995,000 40,740,000 42,193,000 45,594,000 29,057,000 38,932,000 43,954,000  53,993,000 34,772,000 38,587,000 58,197,000 42,630,000 34,060,000 45,935,000 47,004,000 46,428,000 50,752,000 54,466,000 44,767,000 43,875,000 36,742,000 43,239,000 43,190,000 35,580,000 27,656,000 35,475,000 47,894,000 35,311,000 27,783,000 34,719,000 32,906,000 25,403,000 24,598,000 20,345,000 19,899,000 22,834,000 22,964,000 26,083,000 26,029,000 26,365,000 23,232,000 26,928,000 25,827,000 19,255,000 20,329,000 3,651,000 
  contract liabilities11,103,000 10,539,000 10,483,000 9,990,000 9,905,000 7,841,000 8,540,000 8,139,000 7,253,000 5,295,000 5,275,000 4,860,000 4,772,000 3,984,000 3,507,000                                                    
  accrued compensation66,931,000 52,381,000 85,617,000 76,424,000 69,600,000 52,582,000 75,455,000 63,869,000 78,771,000 92,656,000 76,117,000 55,630,000 79,385,000 74,415,000 64,272,000 57,561,000 75,693,000 71,393,000 63,211,000 56,991,000 59,621,000 47,380,000 44,751,000 52,762,000 47,809,000 38,435,000  32,763,000 45,154,000 41,206,000 40,019,000 33,209,000 40,943,000 36,957,000 36,595,000 28,487,000 28,079,000 28,520,000 27,822,000 23,484,000 34,914,000 28,099,000 28,664,000 23,194,000 28,010,000 26,491,000 25,063,000 20,425,000 27,562,000 23,831,000 21,522,000 25,253,000 23,227,000 19,379,000 17,082,000 17,176,000 16,030,000    16,877,000    12,454,000  
  accrued expenses and other current liabilities131,383,000 137,416,000 121,908,000 131,939,000 102,487,000 111,896,000 100,844,000 90,306,000 80,033,000 120,458,000 94,194,000 75,970,000 76,809,000 73,249,000 81,693,000 92,492,000 84,545,000 84,317,000 81,194,000 107,819,000 83,455,000 67,380,000 46,354,000 34,970,000 38,909,000 38,037,000  44,839,000 39,160,000 44,285,000 42,831,000 41,038,000 42,096,000 40,173,000 38,892,000 37,696,000 36,354,000 34,818,000 33,002,000 34,553,000 31,768,000 37,591,000 36,132,000 41,785,000 41,659,000 38,838,000 41,684,000 34,369,000 31,805,000 32,327,000 27,210,000 27,117,000 28,068,000 77,280,000 26,085,000 27,488,000 32,704,000 51,030,000 40,551,000 42,679,000 28,699,000 38,509,000 32,371,000 27,778,000 17,373,000 5,349,000 
  total current liabilities929,806,000 918,452,000 922,126,000 912,563,000 328,316,000 302,394,000 306,980,000 355,712,000 320,906,000 340,021,000 401,013,000 246,485,000 331,309,000 302,641,000 315,111,000 288,106,000 262,552,000 258,340,000 233,342,000 336,020,000 210,234,000 177,877,000 188,083,000 123,601,000 161,397,000 149,827,000  156,630,000 139,127,000 139,947,000 155,753,000 126,805,000 126,025,000 130,123,000 126,902,000 116,831,000 119,382,000 122,278,000 109,339,000 105,780,000 106,929,000 112,574,000 112,247,000 104,586,000 101,868,000 104,433,000 118,008,000 163,316,000 200,032,000 102,704,000 85,639,000 159,180,000 156,730,000 215,320,000 216,834,000 170,671,000 174,751,000 280,602,000 189,235,000 317,113,000 191,671,000 188,185,000 181,025,000 273,744,000 274,017,000 24,475,000 
  long-term borrowings under senior credit facility1,118,142,000 1,128,541,000 1,087,917,000 1,132,292,000 1,151,665,000 1,171,036,000 825,563,000 850,089,000 733,149,000 824,257,000 933,387,000 1,018,032,000 1,198,561,000 1,274,049,000 1,204,537,000 1,205,025,000 1,210,513,000 1,421,001,000 1,476,488,000 1,772,027,000 1,152,633,000 867,500,000 848,750,000 665,000,000 433,750,000 461,250,000  491,563,000 481,875,000 502,188,000 429,375,000 396,250,000 413,125,000 410,000,000 421,875,000 421,875,000 186,875,000 341,875,000 341,875,000 321,875,000 321,875,000 321,875,000 321,875,000 166,875,000 179,688,000 192,500,000 144,375,000 136,875,000 139,688,000 212,500,000 220,000,000 145,000,000 160,000,000 160,000,000 160,000,000 160,000,000 160,000,000          
  long-term borrowings under securitization facility108,800,000 102,100,000 108,100,000 72,800,000 77,700,000 94,600,000 89,200,000  104,700,000 112,500,000  98,500,000 104,500,000 110,000,000 102,400,000 126,000,000 121,200,000                                                  
  lease liability - operating leases159,273,000 161,476,000 166,930,000 167,808,000 169,561,000 170,082,000 166,849,000 168,017,000 157,420,000 90,329,000 88,118,000 100,328,000 97,504,000 96,820,000 94,197,000                                                    
  deferred tax liabilities60,064,000 57,581,000 60,833,000 68,945,000 86,525,000 31,431,000 35,317,000 74,453,000 63,338,000 45,788,000 16,190,000 24,221,000 36,553,000 59,730,000 53,086,000 57,660,000 57,778,000 72,997,000 73,311,000 72,879,000 128,628,000 131,255,000 130,836,000 148,941,000 153,372,000 156,337,000  156,449,000 154,891,000 209,507,000 94,701,000 92,431,000 91,623,000 76,782,000 81,540,000 94,612,000 2,083,000 5,154,000 5,396,000 5,397,000 5,393,000 14,893,000 9,324,000 5,498,000 5,726,000 8,614,000 10,317,000 10,819,000 10,645,000 7,273,000 7,655,000 8,452,000 9,319,000     10,238,000  16,608,000 16,052,000 26,828,000 27,410,000 29,306,000 31,356,000  
  other liabilities253,159,000 160,462,000 146,238,000 189,808,000 154,820,000 139,745,000 199,940,000 142,352,000 138,501,000 120,258,000 186,727,000 158,037,000 118,077,000 118,366,000 100,128,000 131,890,000 80,048,000 61,223,000 60,727,000 68,327,000 13,576,000 29,944,000 28,855,000 30,745,000 30,230,000 28,920,000  28,607,000 28,648,000 29,274,000 31,984,000 32,045,000 30,409,000 31,756,000 34,380,000 36,280,000 12,527,000 12,023,000 12,927,000 14,039,000 13,955,000 13,603,000 17,087,000 16,857,000 11,613,000 18,494,000 16,652,000 11,608,000 11,826,000 12,485,000 16,225,000 17,132,000 20,414,000 20,274,000 21,051,000 19,170,000 19,474,000 18,311,000 19,131,000 20,057,000 19,860,000 6,015,000 5,981,000 6,138,000 11,575,000 349,000 
  total liabilities2,629,244,000 2,528,612,000 2,492,144,000 2,544,216,000 2,540,300,000 2,480,272,000 2,194,104,000 2,160,150,000 2,085,355,000 2,097,579,000 2,100,269,000 2,105,762,000 1,886,504,000 1,961,606,000 1,869,459,000 1,808,681,000 1,732,091,000 1,813,561,000 1,843,868,000 2,249,253,000 1,505,071,000 1,206,576,000 1,196,524,000 968,287,000 1,003,997,000 1,019,375,000  1,053,875,000 1,023,261,000 1,097,520,000 926,171,000 862,708,000 874,303,000 859,756,000 873,793,000 876,723,000 526,049,000 684,595,000 670,912,000 646,602,000 645,824,000 658,805,000 654,605,000 649,919,000 651,471,000 673,145,000 635,039,000 479,442,000 517,345,000 488,476,000 481,419,000 480,077,000 495,217,000 542,814,000 543,597,000 621,148,000 684,225,000 639,151,000 538,366,000 683,778,000 557,583,000 559,680,000 552,976,000 317,528,000 317,456,000 34,205,000 
  stockholders’ equity:                                                                  
  preferred stock; no par value; 15,000 authorized shares; none outstanding                                                                  
  common stock; 0.01 par value; 240,000 authorized shares; 92,337 and 91,610 issued at june 30, 2025 and december 31, 2024, respectively923,000                                                                  
  additional paid-in capital1,328,130,000 1,323,081,000 1,323,431,000 1,316,854,000 1,301,582,000 1,310,527,000 1,302,484,000 1,262,319,000 1,276,977,000 1,264,943,000 1,290,909,000 1,240,455,000 1,213,620,000 1,208,549,000 1,198,010,000 1,191,807,000 1,192,601,000 1,187,963,000 1,177,125,000 822,520,000 817,071,000 812,250,000 799,376,000 798,652,000 1,038,200,000 1,032,970,000  1,022,150,000 1,020,128,000 1,010,448,000 790,371,000 779,074,000 779,555,000 769,208,000 766,096,000 760,817,000 750,918,000 594,078,000 591,331,000 589,948,000 587,301,000 613,721,000 611,337,000 609,849,000 607,676,000 600,852,000 598,249,000 558,527,000 552,227,000 538,651,000 533,863,000 529,848,000 520,849,000 512,385,000 506,882,000 503,130,000 464,668,000 450,261,000 422,178,000 402,006,000 395,266,000 368,544,000 359,727,000 378,772,000 367,277,000 161,564,000 
  treasury stock-690,034,000 -690,379,000 -691,411,000 -691,810,000 -680,753,000 -646,422,000 -647,262,000 -612,777,000 -362,862,000 -234,448,000 -235,141,000 -202,506,000 -119,943,000 -120,101,000 -120,107,000 -120,109,000 -120,615,000 -120,727,000 -120,732,000 -120,734,000 -121,816,000 -122,014,000 -123,051,000 -123,051,000 -367,121,000 -367,121,000  -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -367,121,000 -352,669,000 -340,667,000 -287,978,000 -283,658,000 -283,658,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -252,380,000 -231,914,000 -231,914,000 -156,921,000 -145,846,000 -180,000 
  accumulated other comprehensive loss-30,907,000 -24,106,000  -24,854,000 -18,726,000 -10,646,000    -45,155,000 -74,059,000 -104,588,000 -76,402,000 -87,615,000 -68,700,000 -56,679,000 -45,443,000 -26,271,000 -25,306,000 -1,663,000 -23,783,000 -34,158,000 -51,453,000 -57,154,000 -40,310,000 -43,576,000  -36,665,000 -47,902,000 -41,723,000 -40,288,000 -47,616,000                                  -898,000 
  retained earnings430,549,000 914,622,000 939,915,000 920,481,000 931,176,000 943,578,000 946,859,000 927,025,000 879,118,000 698,568,000 532,265,000 407,553,000 398,574,000 383,255,000 410,865,000 381,129,000 348,373,000 323,236,000 309,941,000 297,500,000 240,831,000 237,673,000 226,837,000 220,443,000 192,195,000 172,052,000  157,563,000 145,879,000 128,038,000 328,341,000 323,344,000 314,960,000 297,794,000 287,987,000 283,162,000 285,046,000 272,863,000 301,413,000 297,973,000 302,023,000 289,237,000 276,026,000 267,512,000 260,819,000 256,259,000 245,018,000 244,317,000 232,830,000 214,024,000 197,540,000 182,383,000 167,161,000 151,430,000 136,998,000 125,773,000 132,219,000 107,374,000 122,666,000 109,740,000 98,175,000 92,768,000 83,094,000 73,752,000 66,336,000  
  total stockholders’ equity1,038,661,000 1,524,139,000 1,545,280,000 1,521,587,000 1,534,195,000 1,597,952,000 1,587,884,000 1,579,221,000 1,804,403,000 1,684,804,000 1,514,867,000 1,341,803,000 1,416,736,000 1,384,974,000 1,420,951,000 1,397,030,000 1,375,796,000 1,365,081,000 1,341,905,000 998,440,000 913,116,000 894,555,000 852,491,000 839,667,000 823,427,000 794,787,000  776,387,000 751,443,000 730,100,000 711,723,000 688,099,000 704,322,000 685,978,000 689,230,000 679,200,000 670,180,000 499,477,000 516,589,000 509,889,000 517,775,000 526,701,000 507,212,000 508,451,000 492,638,000 501,521,000 518,817,000 527,586,000 499,963,000 470,800,000 460,376,000 457,920,000 444,885,000 430,422,000 402,775,000 374,269,000 350,206,000 321,594,000 324,088,000 288,878,000 260,429,000 250,397,000 223,514,000 305,546,000 296,162,000  
  total liabilities and stockholders’ equity3,667,905,000 4,052,751,000 4,037,424,000 4,065,803,000 4,074,495,000 4,078,224,000 3,781,988,000 3,739,371,000 3,889,758,000 3,782,383,000 3,615,136,000 3,447,565,000 3,303,240,000 3,346,580,000 3,290,410,000 3,205,711,000 3,107,887,000 3,178,642,000 3,185,773,000 3,247,693,000 2,418,187,000 2,101,131,000 2,049,015,000 1,807,954,000 1,827,424,000 1,814,162,000  1,830,262,000 1,774,704,000 1,827,620,000 1,637,894,000 1,550,807,000 1,578,625,000 1,545,734,000 1,563,023,000 1,555,923,000 1,196,229,000 1,184,072,000 1,187,501,000 1,156,491,000 1,163,599,000 1,185,506,000 1,161,817,000 1,158,370,000 1,144,109,000 1,174,666,000 1,153,856,000 1,007,028,000 1,017,308,000 959,276,000 941,795,000 937,997,000 940,102,000 973,236,000 946,372,000 995,417,000 1,034,431,000 960,745,000 862,454,000 972,656,000 818,012,000 810,077,000 776,490,000 623,074,000 613,618,000  
  trade accounts receivable, net of allowances of 6,482 and 6,917 252,446,000                                                                 
  common stock; 0.01 par value; 240,000 authorized shares; 92,136 and 91,610 issued at march 31, 2025 and december 31, 2024, respectively 921,000                                                                 
  trade accounts receivable, net of allowances of 6,917 and 4,879  272,370,000                                                                
  long-term convertible securities    571,713,000 570,984,000 570,255,000 569,527,000 567,341,000 564,426,000 474,834,000 460,159,000             225,248,000 223,041,000  220,626,000 218,720,000 216,604,000 214,358,000 215,177,000 213,121,000 211,095,000 209,096,000 207,125,000 205,182,000 203,265,000 201,375,000 199,511,000 197,672,000 195,860,000 194,072,000 356,103,000 352,576,000 349,104,000 345,687,000 156,824,000 155,154,000 153,514,000 151,900,000 150,313,000 148,754,000 147,220,000 145,712,000 271,307,000 330,000,000 330,000,000 330,000,000 330,000,000 330,000,000 330,000,000 330,000,000  508,000  
  common stock; 0.01 par value; 240,000 authorized shares; 91,610 and 90,920 issued at december 31, 2024 and 2023, respectively  916,000                                                                
  accumulated other comprehensive  -27,571,000                                   -713,000 -9,404,000 -11,281,000  -9,495,000 -13,389,000                        
  trade accounts receivable, net of allowances of 7,423 and 4,879   248,298,000                                                               
  common stock; 0.01 par value; 240,000 authorized shares; 91,588 and 90,920 issued at september 30, 2024 and december 31, 2023, respectively   916,000                                                               
  trade accounts receivable, net of allowances of 10,992 and 4,879    271,155,000                                                              
  common stock; 0.01 par value; 240,000 authorized shares; 91,591 and 90,920 issued at june 30, 2024 and december 31, 2023, respectively    916,000                                                              
  trade accounts receivable, net of allowances of 5,050 and 4,879     241,092,000                                                             
  common stock; 0.01 par value; 240,000 authorized shares; 91,484 and 90,920 issued at march 31, 2024 and december 31, 2023, respectively     915,000                                                             
  trade accounts receivable, net of allowances of 4,879 and 4,304      259,327,000                                                            
  common stock; 0.01 par value; 240,000 authorized shares; 90,920 and 90,477 issued at december 31, 2023 and 2022, respectively      909,000                                                            
  accumulated other comprehensive income      -15,106,000 1,745,000 10,265,000                        -23,488,000 -14,318,000 1,853,000 1,927,000 927,000                              
  trade accounts receivable, net of allowances of 5,630 and 4,304       256,270,000                                                           
  prepaid expenses and other current assets       130,976,000 116,789,000 91,051,000 69,282,000 67,332,000 67,907,000 92,091,000 99,576,000 99,627,000 90,160,000 82,408,000 88,654,000 96,520,000 59,534,000 55,563,000 35,477,000 27,666,000 43,858,000 41,170,000  43,894,000 42,620,000 39,361,000 42,397,000 23,958,000 29,632,000 26,886,000 36,758,000 34,496,000 26,752,000 30,739,000 30,774,000 27,396,000 30,291,000 14,366,000 12,162,000 24,571,000 25,904,000 28,330,000 32,794,000 24,807,000 27,869,000 18,501,000 23,455,000 21,081,000 20,032,000 26,189,000 22,636,000 27,420,000 31,191,000 39,013,000 23,538,000 14,318,000 12,264,000 18,615,000 9,778,000 9,441,000 9,649,000 1,937,000 
  current portion of borrowings under securitization facility       75,700,000   112,500,000                                                        
  common stock; 0.01 par value; 240,000 authorized shares; 90,935 and 90,477 issued at september 30, 2023 and december 31, 2022, respectively       909,000                                                           
  trade accounts receivable, net of allowances of 4,304 and 4,735        263,465,000                                                          
  common stock; 0.01 par value; 240,000 authorized shares; 90,477 and 89,600 issued at december 31, 2022 and 2021, respectively        905,000                                                          
  trade accounts receivable, net of allowances of 4,735 and 6,439         231,831,000                                                         
  assets held for sale          162,105,000                                                        
  liabilities held for sale          11,751,000                                                        
  common stock; 0.01 par value; 240,000 authorized shares; 89,600 and 89,251 issued at december 31, 2021 and 2020, respectively         896,000                                                         
  trade accounts receivable, net of allowances of 6,439 and 4,303          225,532,000                                                        
  common stock; 0.01 par value; 240,000 authorized shares; 89,251 and 88,735 issued at december 31, 2020 and 2019, respectively          893,000                                                        
  trade accounts receivable, net of allowances of 6,652 and 4,303           245,546,000                                                       
  commitments and contingencies                                                                  
  common stock; 0.01 par value; 240,000 authorized shares; 89,104 and 88,735 issued at march 31, 2020 and december 31, 2019, respectively           889,000                                                       
  trade accounts receivable, net of allowances of 4,303 and 3,719            275,296,000                                                      
  common stock; 0.01 par value; 240,000 authorized shares; 88,735 and 88,044 issued at december 31, 2019 and 2018, respectively            887,000                                                      
  trade accounts receivable, net of allowances of 4,006 and 3,719             281,119,000                                                     
  common stock; 0.01 par value; 240,000 authorized shares; 88,689 and 88,044 issued at september 30, 2019 and december 31, 2018, respectively             886,000                                                     
  trade accounts receivable, net of allowances of 4,394 and 3,719              296,507,000                                                    
  common stock; 0.01 par value; 240,000 authorized shares; 88,351 and 88,044 issued at june 30, 2019 and december 31, 2018, respectively              883,000                                                    
  trade accounts receivable, net of allowances of 4,099 and 3,719               279,072,000                                                   
  short-term portion of borrowings under senior credit facility               33,750,000  11,250,000  60,000,000 18,750,000 12,500,000 6,250,000                                            
  deferred revenue               3,750,000 3,764,000    7,668,000 8,424,000 8,088,000 6,812,000 6,997,000 8,151,000  7,222,000 5,666,000 4,931,000 4,303,000 4,303,000 5,176,000 5,183,000 4,411,000 4,220,000 4,197,000 4,474,000 3,748,000 3,868,000 3,505,000 3,645,000 4,261,000 4,027,000 4,543,000 3,629,000 3,367,000 3,836,000 4,444,000 4,327,000 4,001,000 3,937,000 4,077,000 4,083,000 3,325,000 3,173,000 3,053,000 3,489,000 2,655,000 3,205,000 2,901,000 2,786,000 2,863,000 3,401,000 4,319,000 1,879,000 
  common stock; 0.01 par value; 240,000 authorized shares; 88,304 and 88,044 issued at march 31, 2019 and december 31, 2018, respectively               882,000                                                   
  trade accounts receivable, net of allowances of 3,719 and 8,882                265,737,000                                                  
  borrowings under senior credit facility                22,500,000        28,750,000 21,250,000  17,813,000 14,375,000 10,938,000 7,500,000 5,625,000 3,750,000 1,875,000              69,375,000 108,438,000      40,000,000 100,000,000 100,000,000 200,000,000 120,000,000 120,000,000    100,000,000 100,000,000  
  short-term portion of contingent consideration                 5,000,000 4,900,000 24,215,000                                               
  common stock; 0.01 par value; 240,000 authorized shares; 88,044 and 81,306 issued at december 31, 2018 and 2017, respectively                880,000                                                  
  trade accounts receivable, net of allowances of 3,897 and 8,882                 248,738,000                                                 
  common stock; 0.01 par value; 240,000 authorized shares; 88,016 and 81,306 issued at september 30, 2018 and december 31, 2017, respectively                 880,000                                                 
  trade accounts receivable, net of allowances of 3,464 and 8,882                  258,380,000                                                
  common stock; 0.01 par value; 240,000 authorized shares; 87,771 and 81,306 issued at june 30, 2018 and december 31, 2017, respectively                  877,000                                                
  trade accounts receivable, net of allowances of 4,596 and 8,882                   272,260,000                                               
  common stock; 0.01 par value; 240,000 authorized shares; 81,711 and 81,306 issued at march 31, 2018 and december 31, 2017, respectively                   817,000                                               
  trade accounts receivable, net of allowances of 6,969 and 6,319                    171,126,000                                              
  common stock; 0.01 par value; 240,000 authorized shares; 81,301 and 77,666 issued at september 30, 2017 and december 31, 2016, respectively                    813,000                                              
  trade accounts receivable, net of allowances of 7,530 and 6,319                     171,323,000                                             
  common stock; 0.01 par value; 240,000 authorized shares; 80,363 and 77,666 issued at june 30, 2017 and december 31, 2016, respectively                     804,000                                             
  trade accounts receivable, net of allowances of 7,529 and 6,319                      158,234,000                                            
  short-term portion of contingent considerations                      37,046,000                                            
  common stock; 0.01 par value; 240,000 authorized shares; 78,185 and 77,666 issued at march 31, 2017 and december 31, 2016, respectively                      782,000                                            
  restricted cash and cash equivalents                            4,073,000                                      
  trade accounts receivable, net of allowances of 6,319 and 5,572                       148,186,000                                           
  common stock; 0.01 par value; 240,000 authorized shares; 77,666 and 91,714 issued at december 31, 2016 and 2015, respectively                       777,000                                           
  trade accounts receivable, net of allowances of 6,173 and 5,572                        140,750,000                                          
  common stock; 0.01 par value; 60,000 authorized shares; 46,258 and 45,857 issued at september 30, 2016 and december 31, 2015, respectively                        463,000                                          
  trade accounts receivable, net of allowances of 6,023 and 5,572                         145,571,000                                         
  common stock; 0.01 par value; 60,000 authorized shares; 46,238 and 45,857 issued at june 30, 2016 and december 31, 2015, respectively                         462,000                                         
  3-month usd libor loan                                                                  
  1-month usd libor loan                                                                  
  total interested rate derivatives designated as cash flow hedge                                                                  
  item 8.                                                                  
  trade accounts receivable, net of allowances of 6,015 and 5,572                           151,607,000                                       
  common stock; 0.01 par value; 60,000 authorized shares; 45,992 and 45,857 issued at march 31, 2016 and december 31, 2015, respectively                           460,000                                       
  trade accounts receivable, net of allowances of 5,572 and 5,659                            132,241,000                                      
  current assets of discontinued operations                                                                  
  non-current assets of discontinued operations                                                                  
  current liabilities of discontinued operations                                                                  
  long-term liabilities of discontinued operations                                                                  
  common stock; 0.01 par value; 60,000 authorized shares; 45,857 and 41,644 issued at december 31, 2015 and 2014, respectively                            459,000                                      
  trade accounts receivable, net of allowances of 5,876 and 5,659                             125,465,000                                     
  common stock; 0.01 par value; 60,000 authorized shares; 45,843 and 41,644 issued at september 30, 2015 and december 31, 2014, respectively                             458,000                                     
  trade accounts receivable, net of allowances of 6,447 and 6,184                              134,546,000                                    
  common stock; 0.01 par value; 60,000 authorized shares; 42,012 and 41,644 issued at june 30, 2015 and december 31, 2014, respectively                              420,000                                    
  trade accounts receivable, net of allowances of 6,515 and 6,184                               126,785,000                                   
  common stock; 0.01 par value; 60,000 authorized shares; 41,755 and 41,644 issued at march 31, 2015 and december 31, 2014, respectively                               418,000                                   
  trade accounts receivable, net of allowances of 6,184 and 6,194                                131,918,000                                  
  common stock; 0.01 par value; 60,000 authorized shares; 41,644 and 41,042 issued at december 31, 2014 and 2013, respectively                                416,000                                  
  trade accounts receivable, net of allowances of 5,161 and 6,194                                 120,741,000                                 
  common stock; 0.01 par value; 60,000 authorized shares; 41,453 and 41,042 issued at september 30, 2014 and december 31, 2013, respectively                                 415,000                                 
  trade accounts receivable, net of allowances of 5,223 and 6,194                                  118,262,000                                
  common stock; 0.01 par value; 60,000 authorized shares; 41,474 and 41,042 issued at june 30, 2014 and december 31, 2013, respectively                                  415,000                                
  trade accounts receivable, net of allowances of 6,287 and 6,194                                   112,521,000                               
  common stock; 0.01 par value; 60,000 authorized shares; 41,449 and 41,042 issued at march 31, 2014 and december 31, 2013, respectively                                   415,000                               
  trade accounts receivable, net of allowances of 6,194 and 7,221                                    118,145,000                              
  common stock; 0.01 par value; 60,000 authorized shares; 41,042 and 36,852 issued at december 31, 2013 and 2012, respectively                                    410,000                              
  trade accounts receivable, net of allowances of 8,159 and 7,221                                     113,538,000                             
  common stock; 0.01 par value; 60,000 authorized shares; 36,972 and 36,852 issued at september 30, 2013 and december 31, 2012, respectively                                     370,000                             
  trade accounts receivable, net of allowances of 9,637 and 7,221                                      114,749,000                            
  common stock; 0.01 par value; 60,000 authorized shares; 36,969 and 36,852 issued at june 30, 2013 and december 31, 2012, respectively                                      370,000                            
  trade accounts receivable, net of allowances of 10,528 and 7,221                                       111,944,000                           
  common stock; 0.01 par value; 60,000 authorized shares; 36,959 and 36,852 issued at march 31, 2013 and december 31, 2012, respectively                                       370,000                           
  trade accounts receivable, net of allowances of 7,221 and 6,978                                        114,916,000                          
  common stock; 0.01 par value; 60,000 authorized shares; 36,852 and 35,734 issued at december 31, 2012 and 2011, respectively                                        369,000                          
  accumulated other comprehensive income:                                                                  
  foreign currency translation adjustment                                        -1,270,000   351,000 -6,494,000 -183,000 17,530,000 12,596,000 -870,000 3,792,000 -18,187,000 -1,483,000 9,746,000 19,700,000 12,039,000 -1,653,000 6,314,000 16,664,000 32,006,000 29,898,000 19,768,000 22,724,000 14,293,000 11,593,000 10,045,000  
  pension liability adjustment, net of tax                                        -1,154,000   -135,000 -131,000 -571,000 -586,000 -509,000 -771,000 -857,000 -821,000 -814,000 -860,000 -1,061,000 -1,111,000 -946,000 -959,000 -665,000 -719,000 -714,000 -723,000   -1,968,000 -1,965,000  
  unrealized gain on derivatives, net of tax                                        -2,373,000    -2,468,000   274,000 -154,000 -1,506,000 8,000 13,000 19,000              
  trade accounts receivable, net of allowances of 6,695 and 6,978                                         119,527,000                         
  common stock; 0.01 par value; 60,000 authorized shares; 35,905 and 35,734 issued at september 30, 2012 and december 31, 2011, respectively                                         359,000                         
  trade accounts receivable, net of allowances of 7,013 and 6,978                                          115,571,000                        
  common stock; 0.01 par value; 60,000 authorized shares 35,902 and 35,734 issued at june 30, 2012 and december 31, 2011, respectively                                          359,000                        
  trade accounts receivable, net of allowances of 6,691 and 6,978                                           113,996,000                       
  property, plant, and equipment                                           136,770,000 131,383,000   102,478,000 99,456,000   83,418,000 83,526,000    70,382,000    61,730,000 55,262,000 50,632,000  42,559,000 11,173,000 
  common stock; 0.01 par value; 60,000 authorized shares; 35,749 and 35,734 issued                                           358,000                       
  unrealized loss on derivatives, net of tax                                           -2,363,000  -2,526,000 -1,087,000                    
  trade accounts receivable, net of allowances of 6,978 and 7,322                                            118,129,000                      
  common stock; .01 par value; 60,000 authorized shares; 35,734 and 35,527 issued                                            357,000                      
  trade accounts receivable, net of allowances of 7,063 and 7,322                                             117,777,000                     
  common stock; 0.01 par value; 60,000 authorized shares; 35,899 and 35,745 issued at september 30, 2011 and december 31, 2010, respectively                                             359,000                     
  trade accounts receivable, net of allowances of 6,825 and 7,322                                              116,179,000                    
  common stock; 0.01 par value; 60,000 authorized shares; 35,860 and 35,745 issued at june 30, 2011 and december 31, 2010, respectively                                              360,000                    
  trade accounts receivable, net of allowances of 6,678 and 7,322                                               106,117,000                   
  common stock; 0.01 par value; 60,000 authorized shares; 35,807 and 35,745 issued                                               359,000                   
  trade accounts receivable, net of allowances of 7,322 and 11,216                                                106,005,000                  
  common stock; .01 par value; 60,000 authorized shares; 35,745 and 34,958 issued                                                359,000                  
  trade accounts receivable, net of allowances of 8,270 and 11,216                                                 107,150,000                 
  short-term borrowings under senior credit facility                                                 7,500,000                 
  common stock; .01 par value; 60,000 authorized shares; 35,419 and 34,958 issued at september 30, 2010 and december 31, 2009, respectively                                                 354,000                 
  trade accounts receivable, net of allowances of 9,578 and 11,216                                                  97,779,000                
  common stock; .01 par value; 60,000 authorized shares; 35,332 and 34,958 issued at june 30, 2010 and december 31, 2009, respectively                                                  353,000                
  trade accounts receivable, net of allowances of 10,429 and 11,216                                                   98,532,000               
  common stock; .01 par value; 60,000 authorized shares; 35,266 and 34,958 issued                                                   353,000               
  trade accounts receivable, net of allowances of 11,216 and 10,052                                                    103,228,000              
  common stock; .01 par value; 60,000 authorized shares; 34,958 and 34,352 issued                                                    350,000              
  trade accounts receivable, net of allowances of 13,027 and 10,052                                                     101,379,000             
  common stock; 0.01 par value; 60,000 authorized shares; 34,808 and 34,352 issued at september 30, 2009 and december 31, 2008, respectively                                                     348,000             
  trade accounts receivable, net of allowances of 10,752 and 10,052                                                      101,462,000            
  common stock; .01 par value; 60,000 authorized shares; 34,743 and 34,352 issued at june 30, 2009 and december 31, 2008, respectively                                                      347,000            
  trade accounts receivable, net of allowances of 9,432 and 10,052                                                       101,610,000           
  common stock: 0.01 par value; 60,000 authorized shares; 34,458 and 34,352 issued at march 31, 2009 and december 31, 2008, respectively                                                       345,000           
  trade accounts receivable, net of allowances of 10,052 and 7,816                                                        112,417,000          
  common stock; .01 par value; 60,000 authorized shares; 34,352 and 32,252 issued                                                        344,000          
  trade accounts receivable, net of allowances of 9,469 and 7,816                                                         111,081,000         
  preferred stock, no par value, 15,000 authorized shares; none outstanding                                                                  
  common stock; .01 par value; 60,000 authorized shares; 33,959 and 32,252 issued at september 30, 2008 and december 31, 2007, respectively                                                         340,000         
  trade accounts receivable, net of allowances of 7,947 and 7,816                                                          108,126,000        
  common stock; .01 par value; 60,000 authorized shares; 33,735 and 32,252 issued at june 30, 2008 and december 31, 2007, respectively                                                          337,000        
  trade accounts receivable, net of allowances of 7,387 and 7,816                                                           106,880,000       
  property, plan and equipment                                                           63,344,000       
  income taxes payable                                                           5,484,000    3,310,000  1,233,000 
  common stock: 0.01 par value; 60,000 authorized shares; 32,792 and 32,252 issued at march 31, 2008 and december 31, 2007, respectively                                                           328,000       
  trade accounts receivable, net of allowances of 7,816 and 4,114                                                            103,539,000      
  common stock; .01 par value; 60,000 authorized shares; 32,252 and 31,464 issued                                                            323,000      
  accounts receivable                                                             92,313,000 95,267,000   12,647,000 
  identifiable intangible assets                                                             181,194,000 183,775,000    
  long-term income taxes payable                                                             8,652,000 8,560,000 8,340,000   
  common stock; 0.01 par value; 60,000 authorized shares; 32,178 and 31,464 issued at september 30, 2007 and december 31, 2006, respectively                                                             322,000     
  minimum pension liability adjustment, net of tax                                                             -2,047,000 -2,006,000    
  common stock; 0.01 par value; 60,000 authorized shares; 32,019 and 31,464 issued at june 30, 2007 and december 31, 2006, respectively                                                              320,000    
  trade accounts receivable, net of allowances of 3,968 and 4,114                                                               85,884,000   
  common stock; 0.01 par value; 60,000 authorized shares; 31,742 and 31,464 issued at march 31, 2007 and december 31, 2006, respectively                                                               318,000   
  investments in marketable securities                                                                  
  trade accounts receivable, net of allowances of 4,114 and 3,508                                                                85,018,000  
  investments in marketable securities, non-current                                                                  
  preferred stock; no par value; 15,000,000 authorized shares; none outstanding                                                                  
  common stock; .01 par value; 60,000 authorized shares; 31,464 and 29,823 issued                                                                315,000  
  unrealized gain on available-for-sale securities, net of tax                                                                  
  goodwill and other intangible assets                                                                 24,378,000 
  liabilities and stockholders' equity                                                                  
  short-term debt                                                                 9,150,000 
  customer advances and deposits                                                                 3,213,000 
  long-term debt                                                                 3,121,000 
  deferred income taxes                                                                 1,717,000 
  stockholders' equity:                                                                  
  preferred stock; 0.01 par value; 15,000 authorized shares; 100 series b convertible shares issued and outstanding at march 31, 2001 and december 31, 2000, 12,000 including a 10% annual cumulative dividend liquidation preference; 54 series c convertible shares issued and outstanding at march 31, 2001 and december 31, 2000, 5,940 including a 10% annual cumulative dividend liquidation preference                                                                 2,000 
  common stock; 0.01 par value; 60,000 authorized shares; 17,658 and 17,334 issued and outstanding at march 31, 2001 and december 31, 2000, respectively                                                                 177,000 
  other                                                                 -58,000 
  accumulated deficit                                                                 -103,733,000 
  total stockholders' equity                                                                 56,874,000 
  total liabilities and stockholders' equity                                                                 91,079,000 

We provide you with 20 years of balance sheets for Integra LifeSciences stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Integra LifeSciences. Explore the full financial landscape of Integra LifeSciences stock with our expertly curated balance sheets.

The information provided in this report about Integra LifeSciences stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.